Chemoinformaics analysis of MALVIDIN-3-RHAMNOSIDE-5-GLUCOSIDE
| Molecular Weight | 639.583 | nRot | 8 |
| Heavy Atom Molecular Weight | 604.303 | nRig | 29 |
| Exact Molecular Weight | 639.192 | nRing | 5 |
| Solubility: LogS | -2.879 | nHRing | 3 |
| Solubility: LogP | -0.354 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 2 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 35 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 16 | No. of Arom Bond | 17 |
| nHA | 15 | APOL | 84.5998 |
| nHD | 9 | BPOL | 47.2642 |
| QED | 0.137 |
| Synth | 4.956 |
| Natural Product Likeliness | 1.728 |
| NR-PPAR-gamma | 0.932 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.994 |
| HIA | 0.931 |
| CACO-2 | -6.429 |
| MDCK | 0.0000952 |
| BBB | 0.384 |
| PPB | 0.665096 |
| VDSS | 0.658 |
| FU | 0.38648 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.073 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.349 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.17 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.209 |
| CYP3a4-inh | 0.002 |
| CYP3a4-sub | 0.005 |
| CL | 2.493 |
| T12 | 0.463 |
| hERG | 0.01 |
| Ames | 0.509 |
| ROA | 0.031 |
| SkinSen | 0.012 |
| Carcinogencity | 0.084 |
| EI | 0.004 |
| Respiratory | 0.023 |
| NR-Aromatase | 0.873 |
| Antiviral | Yes |
| Prediction | 0.818883 |